Loading...
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer
Aim: To report results from the first phase I study of napabucasin plus paclitaxel in Japanese patients with pre-treated unresectable/recurrent gastric cancer. Patients and Methods: Patients received napabucasin (480 mg bid) plus paclitaxel [80 mg/m(2) on days 3, 10 and 17 (cycles 1 and 2) and on da...
Na minha lista:
| Udgivet i: | In Vivo |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Institute of Anticancer Research
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559899/ https://ncbi.nlm.nih.gov/pubmed/31028219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11561 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|